COVID vaccines: What's next, from needle-free patches to nasal sprays
As Eris, a new SARS-CoV-2 sub-variant, takes hold around the world, here's what kind of vaccines could be on the horizon.
Stay updated with breaking news from Adrian Esterman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As Eris, a new SARS-CoV-2 sub-variant, takes hold around the world, here's what kind of vaccines could be on the horizon.
A new variant of COVID-19 may drive an increase in Australian cases in late spring. But it's not expected to cause more serious illness.
A COVID-19 subvariant named EG.5.1, or Eris, is increasingly appearing in the United States and Britain. Symptoms of the subvariant reportedly include a runny nose, headache, fatigue, sneezing and a sore throat, with experts in Australia saying it will emerge here.
In Australia, Arcturus also appears to be the most common subvariant and while no Eris cases have yet been reported, experts say it is likely already in the country.
An ominously nicknamed new COVID-causing variant is spreading quickly across the globe.